Beacon Pointe Advisors’s Alnylam Pharmaceuticals ALNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $338K | Buy |
|
|||||
|
2025
Q1 | $234K | Sell |
|
|||||
|
2024
Q4 | $220K | Sell |
|
|||||
|
2024
Q3 | $378K | Sell |
|
|||||
|
2024
Q2 | $367K | Sell |
|
|||||
|
2024
Q1 | $245K | Hold |
|
|||||
|
2023
Q4 | $313K | Sell |
|
|||||
|
2023
Q3 | $299K | Buy |
|
|||||
|
2023
Q2 | $300K | Sell |
|
|||||
|
2023
Q1 | $342K | Sell |
|
|||||
|
2022
Q4 | $425K | Buy |
|
|||||
|
2022
Q3 | $351K | Buy |
|
|||||
|
2022
Q2 | $235K | Sell |
|
|||||
|
2022
Q1 | $284K | Buy |
|
|||||
|
2021
Q4 | $228K | Sell |
|
|||||
|
2021
Q3 | $293K | Buy |
|